Copegus and Dilantin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Copegus (ribavirin) and Dilantin (phenytoin sodium). Common drug interactions include fatigue among females and pollakiuria among males.
The phase IV clinical study analyzes what interactions people have when they take Copegus and Dilantin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Copegus?
Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.
What is Dilantin?
Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.
13 people who take Copegus and Dilantin together, and have interactions are studied.

What are the common drug interactions of Copegus and Dilantin, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Dizziness
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Headache (pain in head)
- Insomnia (sleeplessness)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Alopecia (absence of hair from areas of the body)
- Blindness
- Death
- Decreased appetite
male:
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Anaemia (lack of blood)
- Malaise (a feeling of general discomfort or uneasiness)
- Nausea (feeling of having an urge to vomit)
- Papule
- Petit mal epilepsy (absence seizure)
- Pyrexia (fever)
- Tooth extraction
- Toothache (tooth pain)
- Weight increased
What are the common drug interactions of Copegus and Dilantin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Fatigue (feeling of tiredness)
- Dizziness
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Headache (pain in head)
- Insomnia (sleeplessness)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Alopecia (absence of hair from areas of the body)
- Blindness
- Death
- Decreased appetite
40-49:
- Abnormal dreams
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Depression
- Disturbance in attention
- Erectile dysfunction
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Hallucination, auditory (perceiving sounds without auditory stimulus)
- Hallucination, visual (seeing things that aren't there)
- Memory impairment
- Rash
50-59:
- Anaemia (lack of blood)
- Anorectal discomfort
- Nausea (feeling of having an urge to vomit)
- Papule
- Petit mal epilepsy (absence seizure)
- Pyrexia (fever)
- Tooth extraction
- Toothache (tooth pain)
- Weight increased
- Asthenia (weakness)
60+:
n/a
What are the existing conditions these people have? *
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%
- Hepatitis (inflammation of the liver): 1 person, 7.69%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Copegus and Dilantin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Copegus and Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Copegus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dilantin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Copegus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dilantin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Akasaka E, Kayo SJ, Nakano H, Ishii N, Hashimoto T, Sawamura D, "Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis", Case reports in dermatology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ribavirin and phenytoin sodium (the active ingredients of Copegus and Dilantin, respectively), and Copegus and Dilantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Acromegaly and Blood Calcium Decreased - 10 seconds ago
- Acne and Sleep Disorder - 14 seconds ago
- Drug interactions of Metformin and Tyvaso Dpi - 18 seconds ago
- Abdominal Discomfort and Hallucinations - 18 seconds ago
- Could Zelnorm cause Crohn'S Disease? - 21 seconds ago
- Drug interactions of Levothroid and Chondroitin - 23 seconds ago
- Abdominal Pain Upper and Oral Pain - 25 seconds ago
- Could Lutein cause Hair Texture Abnormal? - 29 seconds ago
- Drug interactions of Protonix and Colace - 32 seconds ago
- Could Zoledronic Acid cause Malignant Neoplasm Progression? - 32 seconds ago